House Files🔍 SearchSenate ↗House

Organizations

AMRYT PHARMA

On the record as: lobbying client, lobbyists' giving (LD-203).

—
from its PAC to 0 members, 2021 on
$270K
on 11 lobbying reports as a client
$500
its lobbyists report giving 1 members (LD-203)

What its lobbyists report giving members (LD-203)

The members it gave most, colored by party. ◆ marks a member on a committee that handles what it lobbies on.

◆ Gus M. Bilirakis
R-FL · Energy and Commerce
$500
All 1 members
MemberFrom its PACIts lobbyists (LD-203)Sits on, in its lobbying areas
Gus M. Bilirakis R FL—$500Energy and Commerce

Its lobbying, by year

What its quarterly reports (LD-2) total each year: the fees it paid its lobbying firms, or its own lobbying spending when it lobbies for itself. Latest version of each report.

2022: $120K20222023: $150K2023$150K2024: $020242025: $020252026: $02026

What it lobbied on

The lobbying firms it hired

See the data
FirmReportsFees reported
SPLITOAK STRATEGIES LLC7$280K